Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests whether community workshops can lower lead levels in city dwellers

NCT ID NCT07632937

Prevention Sponsor: International Health Strategies LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test if intensive public health campaigns—including workshops, home visits, and cleaning kits—can reduce lead exposure in adults living in urban areas with known lead hazards. Researchers will compare these efforts to standard information pamphlets. The trial aims to enroll 400 participants and track changes in blood lead levels over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intensive Public Health Campaign (behavioral intervention)
What this could lead to
If successful, this could show that community-based campaigns effectively reduce lead exposure and promote safer practices in at-risk urban areas.
What could go wrong
This is a behavioral study with no drug or device; results depend on participant engagement and may not generalize to other communities. It is not yet recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Nov 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Resident of selected urban neighborhoods with documented environmental lead risk * Household includes at least one adult aged 18-75 years willing to participate * Willing to provide informed consent * Willing to allow home visits and blood sampling * Able to understand study procedures and interventions Exclusion Criteria: * Planning to relocate from the area within the next 12 months * Household member with a known diagnosis of severe anemia or bleeding disorder * Participation in another intervention study targeting lead exposure in the past 12 months * Inability or unwillingness to comply with study procedures * Household with known ongoing lead remediation efforts during the study period * Pregnant women (due to additional ethical considerations for blood sampling)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Environmental exposure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lead poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Environmental exposure Lead poisoning

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Philadelphia City Center

    Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.